Autophagy Is Not Regeneration *ABSURD HEALTH INSTITUTE — MEDICAL CONCEPT PAPERS · VOLUME SIX · PAPER 26 Research series: Metabolism as the Switch Article URL upon publication: https://absurd.health/research/volume-six/autophagy-is-not-regeneration/ Abstract. Autophagy recycles cellular material; regeneration rebuilds useful structure and function. This essay distinguishes lysosomal quality control from anatomical repair and examines why nutrient restriction or an autophagy marker cannot by itself prove rejuvenation. It emphasizes adequate substrates, cellular specialization and functional outcomes, especially in frail or undernourished patients. Recycling and rebuilding are different tasks Autophagy is a family of intracellular processes that deliver cellular components to lysosomes for degradation and recycling. It contributes to quality control, nutrient adaptation and cellular homeostasis. But autophagy does not itself recreate a damaged tendon, replace a lost motor neuron or reconnect an injured organ to its blood supply. Some repair processes depend on autophagic activity, while successful tissue regeneration additionally requires proliferation or cell preservation, correct differentiation, matrix remodeling and integration. Why the distinction is frequently lost Interest in fasting, nutrient sensing and molecular longevity has encouraged a simplified narrative: turn on autophagy and the body cleans and rebuilds itself. In reality, autophagic flux differs from accumulation of autophagosome markers, and measuring one protein does not establish effective degradation. Increased autophagy can reflect a healthy response, a stressed cell's attempt to survive or pathological dysregulation. The net effect depends on tissue, duration and underlying disease. The repair sequence Recycling damaged components may improve the performance of surviving cells and provide some substrates, but tissue rebuilding still requires adequate energy, amino acids, micronutrients and biological permission for growth. Persistent catabolic restriction can oppose anabolism and worsen lean-mass loss in vulnerable people. A bone fracture cannot heal properly from intracellular recycling alone. The relevant question is not whether an intervention activates a fashionable longevity marker, but whether it improves a definable part of the repair sequence. What counts as evidence A strong study would measure autophagic flux and actual tissue outcomes while controlling for nutrition and disease severity. A better molecular marker with no improvement in function is not proof of regeneration. Conversely, functional improvement with unchanged autophagic markers would show that this pathway was not the necessary mediator in that context. Autophagy deserves serious biology, not an inflated clinical promise. A clinical thought experiment Autophagic flux could improve in a muscle cell during nutrient stress, yet a patient might lose strength because overall muscle protein balance is negative. Both can be true simultaneously. The same process that helps cells adapt to scarcity does not replace the need for physical loading, amino acids, innervation and tissue-specific rebuilding. The value of molecular cleanup is conditional on the entire organism's state. What would discriminate among explanations The appropriate experiment measures whether autophagic pathways are necessary for the observed functional benefit, not merely whether their markers change. If an intervention increases autophagy but worsens weakness, that is a clinically important negative result. The term 'detoxification' should not be used as a synonym for lysosomal degradation or whole-body toxin excretion. Selected scientific readings - López-Otín C et al. (2023). Hallmarks of aging: An expanding universe. Cell. https://doi.org/10.1016/j.cell.2022.11.001 - Vinten KT et al. (2025). NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism. https://www.nature.com/articles/s42255-025-01387-7 This is an evidence-informed conceptual essay, not a systematic review, clinical trial, validated diagnostic instrument, or treatment recommendation.*